Qentoros | Meet the Fall 2022 Cohort (Part 3)
Posted on: October 24, 2022
Meet our Fall 2022 Cohort (Part 3 of 5).
Qentoros | Michael Miller & Jessica Gilbertie: Qentoros is developing a biologic therapeutic to treat a variety of infectious and/or inflammatory conditions in animals and humans. The biologic is based on blood products and has demonstrated efficacy in treating a number of veterinary patient conditions that did not improve with normal antibiotic treatment. Watch now!
